Literature DB >> 18067962

The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.

David J Browning1, Christina M Fraser, Stephen Clark.   

Abstract

PURPOSE: To examine the relationship of optical coherence tomography (OCT) measured macular thickness to retinopathy severity in patients with diabetes and no clinically detectable macular edema.
DESIGN: Retrospective observational case series. PARTICIPANTS: Three hundred eighty-three eyes of 383 patients of a private retina practice; including 100 normal eyes of patients without diabetes, 100 eyes of diabetics without retinopathy, 100 eyes of diabetics with mild to moderate retinopathy, 35 eyes of diabetics with severe nonproliferative or proliferative retinopathy, and 48 eyes of diabetics with regressed proliferative retinopathy.
METHODS: Review of clinical charts and optical coherence tomography measurements. MAIN OUTCOME MEASURES: Central subfield mean thickness (CSMT), inner and outer zone measurements, and total macular volume.
RESULTS: Central subfield mean thicknesses (mean +/- standard deviation) were 208+/-22, 198+/-25, 204+/-26, 224+/-38, and 205+/-27 microm for normals, eyes of diabetics without retinopathy, eyes with mild to moderate nonproliferative retinopathy, eyes with severe nonproliferative to proliferative retinopathy, and eyes with regressed proliferative retinopathy, respectively. For all groups, mean CSMT was larger in males than in females. Statistically significant differences by gender were observed for normals, diabetics without retinopathy, and diabetics with mild to moderate nonproliferative retinopathy (mean differences, 12, 14, and 18 microm, respectively; Ps = 0.0057, 0.0057, and 0.0002). For increasing retinopathy severity, the probability of macular thickening detected by OCT but not detected by clinical examination increased. Fifteen percent of eyes with severe nonproliferative or proliferative retinopathy and no clinically detected edema had OCT-measured macular thickening.
CONCLUSIONS: Because OCT measurements are gender dependent, gender balance or statistical adjustment for gender imbalances of compared groups in OCT studies of diabetic macular edema is important. As retinopathy severity increases, the probability of subclinical edema rises. Except for an individual baseline measurement possibly useful for longitudinal comparison, the data suggest that there is little reason routinely to obtain OCT in eyes with diabetes and no retinopathy or mild to moderate diabetic retinopathy when clinical examination fails to show macular edema.

Entities:  

Mesh:

Year:  2007        PMID: 18067962     DOI: 10.1016/j.ophtha.2007.06.042

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Ratiometric analysis of optical coherence tomography-measured in vivo retinal layer thicknesses for the detection of early diabetic retinopathy.

Authors:  Basanta Bhaduri; Ryan L Shelton; Ryan M Nolan; Lucas Hendren; Alexandra Almasov; Leanne T Labriola; Stephen A Boppart
Journal:  J Biophotonics       Date:  2017-06-21       Impact factor: 3.207

2.  [Ranibizumab in diabetic macular edema. Evaluation of functional and morphological aspects].

Authors:  L Reznicek; S Cserhati; R Liegl; F Seidensticker; C Haritoglou; A Wolf; A Kampik; M W Ulbig; A Neubauer; M Kernt
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

Review 3.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.

Authors:  Gianni Virgili; Francesca Menchini; Giovanni Casazza; Ruth Hogg; Radha R Das; Xue Wang; Manuele Michelessi
Journal:  Cochrane Database Syst Rev       Date:  2015-01-07

4.  Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study.

Authors:  Troels Brynskov; Caroline Schmidt Laugesen; Annette Lykke Svenningsen; Andrea Karen Floyd; Torben Lykke Sørensen
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

5.  Blood pressure, vessel caliber, and retinal thickness in diabetes.

Authors:  Wendy W Harrison; Ann Chang; Maria G Cardenas; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Optom Vis Sci       Date:  2012-12       Impact factor: 1.973

6.  Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.

Authors:  Radha Das; Gareth Spence; Ruth E Hogg; Michael Stevenson; Usha Chakravarthy
Journal:  JAMA Ophthalmol       Date:  2018-02-01       Impact factor: 7.389

7.  Optical coherence tomography imaging for diabetic retinopathy and macular edema.

Authors:  John C Buabbud; Motasem M Al-latayfeh; Jennifer K Sun
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

8.  Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy.

Authors:  Hille W van Dijk; Frank D Verbraak; Marilette Stehouwer; Pauline H B Kok; Mona K Garvin; Milan Sonka; J Hans DeVries; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Vision Res       Date:  2010-08-27       Impact factor: 1.886

9.  Diabetic retinopathy and peripapillary retinal thickness.

Authors:  Hee Yoon Cho; Dong Hoon Lee; Song Ee Chung; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2010-02-05

10.  Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.

Authors:  Hille W van Dijk; Pauline H B Kok; Mona Garvin; Milan Sonka; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Frank D Verbraak; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.